HOME >> BIOLOGY >> NEWS
Drug overuse may make yeast infections harder to treat

The indiscriminate use of over-the-counter treatments and the misuse of prescriptions by women afflicted with yeast infections may make the condition more difficult to treat in the future, says a group of University of Toronto researchers.

Laboratory experiments by U of T at Mississauga botany professors Linda Kohn and James Anderson and grad student Leah Cowen show that cells repeatedly exposed to azole drugs - the most commonly used and prescribed anti-fungal treatments for yeast infections - develop resistance to that drug.

"It was assumed that when you finish a course of drug therapy, you have killed off all of the fungus or infection. If there are any drug resistant organisms left, it was thought that they'd be weaker, wouldn't grow as well and just die out," explains Kohn. However, her work with Anderson and Cowen runs counter to that assumption.

"Our research has shown that drug resistant microbes not only compete well, they are able to evolve and adapt to overcome problems or weaknesses relatively easily," adds Anderson. "In some populations, the drug resistant microbes even grew faster and started to overtake the microbes that showed no drug resistance." And that is worrisome, say the researchers, especially if a person gets sick again. The infection may not be more virulent, but it could be resistant to the original drug, and that means taking the same drug therapy may not help.

About 75 per cent of all women between 18 and 35 will experience at least one yeast infection caused by Candida albicans, one of the most common types of yeast fungus.


'"/>

Contact: Janet Wong
jf.wong@utoronto.ca
416- 978-6974
University of Toronto
17-Oct-2000


Page: 1

Related biology news :

1. Purdue yeast makes ethanol from agricultural waste more effectively
2. Carnegie Mellon U biologists identify critical player in yeast ribosome assembly
3. Protein-only prions confirmed in FSU yeast study
4. Bakers yeast rises from genome duplication
5. Building a better atlas of yeast proteins
6. New findings in yeast may reveal why growing older is the greatest carcinogen in humans
7. Dartmouth bioengineers develop humanized yeast
8. First production of a human protein with complex glycosylation in genetically modified yeast
9. Molecules discovered that extend life in yeast, human cells
10. Scientists at TSRI create new strain of yeast with 21-amino acid genetic code
11. Pathogenic yeasts and fungi: A growing health concern

Post Your Comments:
*Name:
*Comment:
*Email:


(Date:5/14/2020)... ... 13, 2020 , ... DuPont Nutrition & Biosciences (DuPont) today ... dairy market. This unique product allows for process optimization and cost reduction, enabling ... across North America. , Among the numerous benefits Bonlacta™ offers, it is fast ...
(Date:5/1/2020)... ... April 30, 2020 , ... USARAD ... Healthineers and several healthcare VC firms announces an official launch of CareDoctors.com. In ... to enhance patient care experience by offering live video consultations with board certified ...
(Date:4/30/2020)... ... April 28, 2020 , ... Ever ... latest effort in providing timely and critical information to life science organizations as ... and health safety concerns. , “Providing the most up-to-date actionable guidance and information ...
Breaking Biology News(10 mins):
(Date:5/15/2020)... (PRWEB) , ... May 15, 2020 , ... Sentien Biotechnologies, ... appointment of Richard Ganz as Executive Chairman. Mr. Ganz will continue to lead ... as well as work closely with CEO Brian Miller and Sentien’s management team. ...
(Date:5/14/2020)... ... 13, 2020 , ... Early stages of drug discovery often ... information on the drug’s mechanism of action (MOA). Gene expression profiling technologies like ... activity of molecular pathways. This information can complement phenotypic readouts and can be ...
(Date:5/5/2020)... (PRWEB) , ... May 05, 2020 , ... ... solutions company, announced today the launch of its iGlucose® LTE Cat-M ... iGlucose solution utilizes LTE Cat-M1 technology, the industry’s newest and broadest cellular connectivity ...
(Date:4/22/2020)... ... April 20, 2020 , ... Global molecular ... today that Omixon’s founder and chairman Dr. Attila Berces returns as CEO. Outgoing ... HLA since 2014 before stepping into the CEO role in 2017. , ...
Breaking Biology Technology:
Cached News: